메뉴 건너뛰기




Volumn 340, Issue 7748, 2010, Pages 667-

Monitoring HPV vaccination programmes

Author keywords

[No Author keywords available]

Indexed keywords

AS 04; HEPATITIS A VACCINE; UNCLASSIFIED DRUG; WART VIRUS VACCINE;

EID: 77950268819     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.c1666     Document Type: Editorial
Times cited : (8)

References (12)
  • 1
    • 77950258317 scopus 로고    scopus 로고
    • Risk of miscarriage with bivalent vaccine against human papillomavirus (HPV) types 16 and 18: Pooled analysis of two randomised controlled trials
    • for the CVT group. Abstract/Free Full Text
    • Wacholder S, Chen BE, Wilcox A, Macones G, Gonzalez P, Befano B, et al; for the CVT group. Risk of miscarriage with bivalent vaccine against human papillomavirus (HPV) types 16 and 18: pooled analysis of two randomised controlled trials. BMJ 2010;340:c712.[Abstract/Free Full Text]
    • (2010) BMJ , vol.340
    • Wacholder, S.1    Chen, B.E.2    Wilcox, A.3    Macones, G.4    Gonzalez, P.5    Befano, B.6
  • 2
    • 0008348082 scopus 로고    scopus 로고
    • Revision 5
    • European Medicines Agency. Cervarix European public assessment report. Revision 5. 2009.www.ema.europa.eu/humandocs/Humans/EPAR/cervarix/cervarix.htm.
    • (2009) Cervarix European Public Assessment Report
  • 3
    • 84881316130 scopus 로고    scopus 로고
    • Vaccines, blood and biologics
    • US Food and Drug Administration: vaccines, blood and biologics. Cervarix. www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm186957.htm.
    • Cervarix
  • 4
    • 84881311267 scopus 로고    scopus 로고
    • Suspected adverse reaction analysis
    • UK Medicines and Healthcare products Regulatory Agency. Suspected adverse reaction analysis.Cervarix human papillomavirus (HPV) vaccine. 2010. www.mhra.gov.uk/Safetyinformation/Generalsafetyinformationandadvice/ Product-specificinformationandadvice/HumanpapillomavirusHPVvaccine/CON023340.
    • (2010) Cervarix Human Papillomavirus (HPV) Vaccine
  • 5
    • 77951705195 scopus 로고    scopus 로고
    • Health Protection Agency. Annual HPV vaccine uptake in England: 2008/09. 2010. www.dh.gov.uk/dr-consum-dh/groups/dh-digitalassets/@dh/@en@ps/documents/ digitalasset/dh-111676.pdf.
    • (2010) Annual HPV Vaccine Uptake in England: 2008/09
  • 6
    • 67651049056 scopus 로고    scopus 로고
    • Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): Final analysis of a double-blind, randomised study in young women
    • [CrossRef][Web of Science][Medline]
    • Paavonen J, Naud P, Salmeron J, Wheeler C, Chow SN, Apter D, et al. Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. Lancet 2009;374:301-314[CrossRef][Web of Science][Medline]
    • (2009) Lancet , vol.374 , pp. 301-314
    • Paavonen, J.1    Naud, P.2    Salmeron, J.3    Wheeler, C.4    Chow, S.N.5    Apter, D.6
  • 7
    • 70449717381 scopus 로고    scopus 로고
    • Global Advisory Committee on Vaccine Safety, report of meeting held 17-18 June 2009
    • WHO
    • WHO. Global Advisory Committee on Vaccine Safety, report of meeting held 17-18 June 2009. Wkly Epidemiol Rec 2009;32:325-332
    • (2009) Wkly Epidemiol Rec , vol.32 , pp. 325-332
  • 8
    • 73349127849 scopus 로고    scopus 로고
    • Pregnancy outcomes from the pregnancy registry of a human papillomavirus type 6/11/16/18 vaccine
    • [CrossRef][Web of Science][Medline]
    • Dana A, Buchanan KM, Goss MA, Seminack MM, Shields KE, Korn S, et al. Pregnancy outcomes from the pregnancy registry of a human papillomavirus type 6/11/16/18 vaccine. Obstet Gynecol 2009;114:1170-1178[CrossRef][Web of Science][Medline]
    • (2009) Obstet Gynecol , vol.114 , pp. 1170-1178
    • Dana, A.1    Buchanan, K.M.2    Goss, M.A.3    Seminack, M.M.4    Shields, K.E.5    Korn, S.6
  • 9
    • 73349128149 scopus 로고    scopus 로고
    • Pregnancy and infant outcomes in the clinical trials of a human papillomavirus type 6/11/16/18 vaccine: A combined analysis of five randomized controlled trials
    • [CrossRef][Web of Science][Medline]
    • Garland SM, Ault KA, Gall SA, Paavonen J, Sings HL, Ciprero KL, et al. Pregnancy and infant outcomes in the clinical trials of a human papillomavirus type 6/11/16/18 vaccine: a combined analysis of five randomized controlled trials. Obstet Gynecol 2009;114:1179-1188[CrossRef][Web of Science][Medline]
    • (2009) Obstet Gynecol , vol.114 , pp. 1179-1188
    • Garland, S.M.1    Ault, K.A.2    Gall, S.A.3    Paavonen, J.4    Sings, H.L.5    Ciprero, K.L.6
  • 10
    • 67651031934 scopus 로고    scopus 로고
    • Safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine for cervical cancer prevention: A pooled analysis of 11 clinical trials
    • [Web of Science][Medline]
    • Descamps D, Hardt K, Spiessens B, Izurieta P, Verstraeten T, Breuer T, et al. Safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine for cervical cancer prevention: a pooled analysis of 11 clinical trials. Hum Vaccin 2009;5:332-340[Web of Science][Medline]
    • (2009) Hum Vaccin , vol.5 , pp. 332-340
    • Descamps, D.1    Hardt, K.2    Spiessens, B.3    Izurieta, P.4    Verstraeten, T.5    Breuer, T.6
  • 11
    • 77649271813 scopus 로고    scopus 로고
    • Predicted impact of vaccination against human papillomavirus 16/18 on cancer incidence and cervical abnormalities in women aged 20-29 in the UK
    • [CrossRef][Web of Science][Medline]
    • Cuzick J, Castanon A, Sasieni P. Predicted impact of vaccination against human papillomavirus 16/18 on cancer incidence and cervical abnormalities in women aged 20-29 in the UK. Br J Cancer 2010;102:933-939 [CrossRef][Web of Science][Medline]
    • (2010) Br J Cancer , vol.102 , pp. 933-939
    • Cuzick, J.1    Castanon, A.2    Sasieni, P.3
  • 12
    • 32144454702 scopus 로고    scopus 로고
    • Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: Systematic review and meta-analysis
    • [CrossRef][Web of Science][Medline]
    • Kyrgiou M, Koliopoulos G, Martin-Hirsch P, Arbyn M, Prendiville W, Paraskevaidis E. Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis. Lancet 2006;367:489-498[CrossRef][Web of Science][Medline]
    • (2006) Lancet , vol.367 , pp. 489-498
    • Kyrgiou, M.1    Koliopoulos, G.2    Martin-Hirsch, P.3    Arbyn, M.4    Prendiville, W.5    Paraskevaidis, E.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.